Literature DB >> 1879306

Intranasal administration of insulin to humans.

S Gizurarson1, E Bechgaard.   

Abstract

The purpose of this review is to summarize the information and experience at present available on the intranasal administration of insulin to human subjects and to describe some of the anatomical, physiological, pharmaceutical and technological factors which can affect the absorption of insulin. An overview is given of those absorption promoters which have been used in clinical insulin studies, and the possible absorption-promoting mechanisms are discussed. This review shows that the nasal route offers a promising alternative to parenteral administration. The easier administration and the acceptance by the patients is encouraging the development of new intranasal insulin preparations.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1879306     DOI: 10.1016/0168-8227(91)90083-p

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  7 in total

Review 1.  Antigen-specific therapy for autoimmune disease: prospects for the prevention of insulin-dependent diabetes.

Authors:  L C Harrison
Journal:  Mol Med       Date:  1995-11       Impact factor: 6.354

2.  A semisynthetic Quillaja saponin as a drug delivery agent for aminoglycoside antibiotics.

Authors:  J Recchia; M H Lurantos; J A Amsden; J Storey; C R Kensil
Journal:  Pharm Res       Date:  1995-12       Impact factor: 4.200

Review 3.  Intranasal insulin. Clinical pharmacokinetics.

Authors:  L Illum; S S Davis
Journal:  Clin Pharmacokinet       Date:  1992-07       Impact factor: 6.447

4.  No effect of adjunctive, repeated-dose intranasal insulin treatment on psychopathology and cognition in patients with schizophrenia.

Authors:  Xiaoduo Fan; Emily Liu; Oliver Freudenreich; Paul Copeland; Douglas Hayden; Musie Ghebremichael; Bruce Cohen; Dost Ongur; Donald C Goff; David C Henderson
Journal:  J Clin Psychopharmacol       Date:  2013-04       Impact factor: 3.153

5.  Uptake of melatonin into the cerebrospinal fluid after nasal and intravenous delivery: studies in rats and comparison with a human study.

Authors:  Mascha P van den Berg; Paul Merkus; Stefan G Romeijn; J Coos Verhoef; Frans W H M Merkus
Journal:  Pharm Res       Date:  2004-05       Impact factor: 4.200

Review 6.  Evolving strategies for insulin delivery and therapy.

Authors:  William T Cefalu
Journal:  Drugs       Date:  2004       Impact factor: 9.546

7.  Quercetin solid lipid microparticles: a flavonoid for inhalation lung delivery.

Authors:  Santo Scalia; Mehra Haghi; Vanessa Losi; Valentina Trotta; Paul M Young; Daniela Traini
Journal:  Eur J Pharm Sci       Date:  2013-03-26       Impact factor: 4.384

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.